A previous study of LAG-3 expression in BC suggested that LAG-3 expression was more frequently observed in ER- BC BCs compared with ER+ BCs, and LAG-3 expression in TILs was associated with better prognosis compared with TNBC without LAG-3 expression (23). This evidence concerns the gene ESR1 and breast cancer.